Suchergebnisse - "Prostatic Neoplasms / pathology"

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

Autoren: Weiner, Adam B Agrawal, Raag Wang, Nicholas K et al.

Quelle: European Urology. 86(6)

Schlagwörter: 32 Biomedical and Clinical Sciences (for-2020), 3202 Clinical Sciences (for-2020), 3211 Oncology and Carcinogenesis (for-2020), Cancer (rcdc), Aging (rcdc), Urologic Diseases (rcdc), Health Disparities (rcdc), Prostate Cancer (rcdc), Biomedical Imaging (rcdc), Genetics (rcdc), Radiation Oncology (rcdc), Minority Health (rcdc), Cancer (hrcs-hc), Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Aged (mesh), Positron-Emission Tomography (mesh), Biomarkers, Tumor (mesh), Middle Aged (mesh), Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Humans, Gene expression, Biomarkers, Tumor, Prognosis, Gene expression profiling, Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Positron-Emission Tomography (mesh), Aged (mesh), Middle Aged (mesh), Male (mesh), Biomarkers, Tumor (mesh), Biomarkers, Gene expression, Gene expression profiling, Humans, Prognosis, Prostatic neoplasms/genetics, Prostatic neoplasms/pathology, Tumor, Male (mesh), Humans (mesh), Prostatic Neoplasms (mesh), Glutamate Carboxypeptidase II (mesh), Antigens, Surface (mesh), Aged (mesh), Positron-Emission Tomography (mesh), Biomarkers, Tumor (mesh), Middle Aged (mesh), 1103 Clinical Sciences (for), Urology & Nephrology (science-metrix), 3202 Clinical sciences (for-2020)

Dateibeschreibung: application/pdf

Zugangs-URL: https://escholarship.org/uc/item/9bt5w5vj
https://escholarship.org/content/qt9bt5w5vj/qt9bt5w5vj.pdf

Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results

Autoren: J. Rubio‐Briones A. Borque‐Fernando L. M. Esteban Escaño et al.

Quelle: Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza

Schlagwörter: Aged, 80 and over, Male, Persona de Mediana Edad, Anciano, España, Prostatic Neoplasms, Neoplasias de la Próstata, Middle Aged, Estudios Longitudinales, Sistema de Registros, Magnetic Resonance Imaging, Anciano de 80 o más Años, Humanos, Spain, Humans, Aged Aged, 80 and over Humans Longitudinal Studies Magnetic Resonance Imaging Male Middle Aged Prostatic Neoplasms* / diagnosis Prostatic Neoplasms* / epidemiology Prostatic Neoplasms* / mortality Prostatic Neoplasms* / pathology Prostatic Neoplasms* / therapy Registries Spain / epidemiology Watchful Waiting* / statistics & numerical data, Longitudinal Studies, Registries, Espera Vigilante, Watchful Waiting, Masculino, Imagen por Resonancia Magnética, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: http://zaguan.unizar.es/record/162740
https://hdl.handle.net/20.500.13003/25885

Circulating innate lymphoid cells are dysregulated in patients with prostate cancer

Autoren: Maresca D. C. La Civita E. Romano B. et al.

Quelle: Cell Mol Biol Lett
Cellular & Molecular Biology Letters, Vol 30, Iss 1, Pp 1-23 (2025)
Cellular & molecular biology letters, vol. 30, no. 1, pp. 48

Schlagwörter: Prostatic Neoplasms / pathology, Lymphocytes / metabolism, Male, Innate lymphoid cells, Prostatic Neoplasms / immunology, 616.07, ILC2s, IL-13, IL-18, IL-33, ILC1s, Prostate cancer, Cell Line, Tumor, Humans, Prostatic Neoplasms/immunology, Prostatic Neoplasms/pathology, Prostatic Neoplasms/blood, Immunity, Innate, Lymphocytes/immunology, Lymphocytes/metabolism, Lymphocytes/pathology, Middle Aged, Cytokines/metabolism, Cytokines/blood, Aged, Leukocytes, Mononuclear/immunology, Lymphocytes, QH573-671, Prostatic Neoplasms / blood, Leukocytes, Mononuclear / immunology, Prostatic Neoplasms, Cytokines / blood, Cytokines / metabolism, Leukocytes, Mononuclear, Lymphocytes / pathology, Cytokines, Lymphocytes / immunology, Cytology, Research Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40247153
https://doaj.org/article/71b194f34d0b4f3d819b24c3a1ddabcd
https://hdl.handle.net/11588/1006455
https://archive-ouverte.unige.ch/unige:186016
https://doi.org/10.1186/s11658-025-00725-7
https://serval.unil.ch/resource/serval:BIB_C66FE4F0E846.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C66FE4F0E8468
https://serval.unil.ch/notice/serval:BIB_C66FE4F0E846

The Immune Microenvironment in Prostate Cancer: A Comprehensive Review

Autoren: Rene Novysedlak Miray Guney Majd Al Khouri et al.

Quelle: Oncology
Oncology, vol. 103, no. 6, pp. 521-545

Schlagwörter: Humans, Prostatic Neoplasms/immunology, Prostatic Neoplasms/pathology, Prostatic Neoplasms/therapy, Tumor Microenvironment/immunology, Male, T-Lymphocytes, Regulatory/immunology, Tumor-Associated Macrophages/immunology, Immunotherapy/methods, CD4, CD8, Immunology, Immunotherapy, Metastatic, Myeloid-derived suppressor cells, Neutrophils, Prostate tumor, T cells, Tertiary lymphoid structures, Tumor-associated macrophages, Review

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39380471
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F33B7BC8896A2
https://serval.unil.ch/resource/serval:BIB_F33B7BC8896A.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_F33B7BC8896A

Expression of BRCA1 and BRCA2 Genes in Patients Undergoing Transrectal Prostate Biopsy

Autoren: Eduardo Maciel Narvaes Alyna Araújo e Marcondes Roberto de Andrade Garcia Filho et al.

Quelle: Revista Brasileira de Cancerologia, Vol 72, Iss 1 (2025)

Schlagwörter: Prostatic Neoplasms/pathology, Genes, BRCA1, Genes, BRCA2, Gene Expression, Neoplasm Grading/statistics & numerical data, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Dateibeschreibung: electronic resource

Relation: https://rbc.inca.gov.br/index.php/revista/article/view/5460; https://doaj.org/toc/0034-7116; https://doaj.org/toc/2176-9745

Zugangs-URL: https://doaj.org/article/ae0b03dda4874b9991aca840f0de6ca5

Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer

Autoren: Pope, Bernard Park, Gahee Lau, Edmund et al.

Weitere Verfasser: Pope, Bernard Park, Gahee Lau, Edmund et al.

Quelle: Pan Prostate Cancer Group (PPCG) 2024, 'Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer', European Urology, vol. 85, no. 4, pp. 407-410. https://doi.org/10.1016/j.eururo.2024.01.002

Schlagwörter: Neoplasm recurrence, MCC, Male, Prostatectomy, Circulating Tumor DNA/genetics, local/genetics, Prostatic Neoplasms, Prostatic Neoplasms/pathology, Prostate-Specific Antigen, Circulating tumor DNA/genetics, Prostate-specific antigen, Local/genetics, Circulating Tumor DNA, Neoplasm Recurrence, SDG 3 - Good Health and Well-being, DPW-DAS, Humans, Neoplasm Recurrence, Local/genetics, Neoplasm Recurrence, Local, Prostatic neoplasms/pathology

Dateibeschreibung: application/vnd.openxmlformats-officedocument.wordprocessingml.document; application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38378299
https://research.manchester.ac.uk/en/publications/7f270596-adbb-433e-850b-7c85e31da48e
https://doi.org/10.1016/j.eururo.2024.01.002
https://ueaeprints.uea.ac.uk/id/eprint/94485/
https://research.manchester.ac.uk/en/publications/7f270596-adbb-433e-850b-7c85e31da48e
http://www.scopus.com/inward/record.url?scp=85187497372&partnerID=8YFLogxK
https://www.mendeley.com/catalogue/89d6cabf-a7ca-37ab-a10a-e8a9e71d91b1/
https://doi.org/10.1016/j.eururo.2024.01.002

Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival

Autoren: Siech C. de Angelis M. Di Bello F. et al.

Quelle: Ann Surg Oncol

Schlagwörter: Male, Adult, Leiomyosarcoma, Prostatectomy, Prostatic Neoplasms, Sarcoma, Middle Aged, Prognosis, Cancer-specific mortality, Mesenchymal tumor, Prostate cancer, SEER, Variant histology, Combined Modality Therapy, Survival Rate, Rhabdomyosarcoma, Humans, Original Article, Aged [MeSH], Prostatic Neoplasms/mortality [MeSH], Prostatic Neoplasms/pathology [MeSH], Sarcoma/mortality [MeSH], Leiomyosarcoma/therapy [MeSH], Male [MeSH], Sarcoma/therapy [MeSH], Combined Modality Therapy [MeSH], Follow-Up Studies [MeSH], Leiomyosarcoma/mortality [MeSH], SEER Program [MeSH], Adult [MeSH], Humans [MeSH], Leiomyosarcoma/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Survival Rate [MeSH], Sarcoma/pathology [MeSH], Prostatectomy/mortality [MeSH], Rhabdomyosarcoma/therapy [MeSH], Prognosis [MeSH], Prostatic Neoplasms/therapy [MeSH], Rhabdomyosarcoma/mortality [MeSH], Rhabdomyosarcoma/pathology [MeSH], SEER Program, Aged, Follow-Up Studies, Retrospective Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39313727
https://repository.publisso.de/resource/frl:6505635

Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer

Autoren: Eva Welsch Lilli Bonstingl Barbara Holzer et al.

Quelle: Clin Exp Metastasis

Schlagwörter: Male, Glutamate Carboxypeptidase II, Aged, 80 and over, Neoplastic Cells, Circulating/pathology [MeSH], Follow-Up Studies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Parsortix, Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], Liquid biopsy, Neoplasm Metastasis [MeSH], Prostatic Neoplasms/blood [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Antigens, Surface [MeSH], Glutamate Carboxypeptidase II/blood [MeSH], Research Paper, In Situ Hybridization [MeSH], Male [MeSH], Biomarkers, Tumor/blood [MeSH], Biomarkers, Tumor/genetics [MeSH], Prognosis [MeSH], qPCR, Gene expression, Circulating tumor cells, Prostate cancer, Prostatic Neoplasms, Middle Aged, Prostate-Specific Antigen, Neoplastic Cells, Circulating, Prognosis, Antigens, Surface, Biomarkers, Tumor, Humans, Neoplasm Metastasis, In Situ Hybridization, Aged, Follow-Up Studies

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39305397
https://repository.publisso.de/resource/frl:6518781

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Autoren: De Laere, Bram Crippa, Alessio Discacciati, Andrea et al.

Weitere Verfasser: De Laere, Bram Crippa, Alessio Discacciati, Andrea et al.

Quelle: Nat Med

Schlagwörter: Male, 0301 basic medicine, Taxoids/therapeutic use, Oncologie, Receptors, Androgen/metabolism, Prostatic Neoplasms/pathology, Sciences de la santé humaine, Article, Circulating Tumor DNA, Prostatic Neoplasms, Castration-Resistant/genetics, Circulating Tumor DNA/blood, 03 medical and health sciences, 0302 clinical medicine, Androgen Receptor Antagonists, Biomarkers, Tumor, Humans, Human health sciences, Neoplasm Metastasis, Aged, Aged, 80 and over, Cancer och onkologi, Prostatic Neoplasms, Castration-Resistant/drug therapy, Prostatic Neoplasms, Castration-Resistant/pathology, Biochemistry, Genetics and Molecular Biology (all), Circulating Tumor DNA/genetics, Prostatic Neoplasms/genetics, Androgen Receptor Antagonists/therapeutic use, Prostatic Neoplasms, Bayes Theorem, Middle Aged, Receptors, Androgen/genetics, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, Oncology, Receptors, Androgen, Cancer and Oncology, Prostatic Neoplasms/drug therapy, Taxoids, Biomarkers, Tumor/genetics

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39164518
https://hdl.handle.net/2268/324387
https://doi.org/10.1038/s41591-024-03204-2
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-546541
https://publications.scilifelab.se/publication/dee72ceeb5c04e68a9949a9f0a6611c0

Aktueller Behandlungsstandard und Trends der Systemtherapie beim metastasierten hormonsensiblen Prostatakarzinom – Anwendung der Studiendaten in der Praxis

Autoren: Wenzel, Mike Banek, Séverine Chun, Felix K. H. et al.

Quelle: Urologie

Schlagwörter: Originalien, Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Triplet-Therapie, Androgen Antagonists/administration, Prostatakrebs, Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Clinical Trials, Phase III as Topic [MeSH], Androgen Antagonists/therapeutic use [MeSH], Male [MeSH], Prostatic neaplasms, Androgenrezeptorsignalweg, Humans [MeSH], Neoplasm Metastasis [MeSH], Prospective Studies [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Middle Aged [MeSH], ARSI, Androgen receptor signaling inhibitor, Chemotherapy, Chemotherapie, Triplet therapy, 3. Good health

Zugangs-URL: https://repository.publisso.de/resource/frl:6513332

Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population

Autoren: Hein V. Stroomberg Signe Benzon Larsen Torben Kjær Nielsen et al.

Quelle: Stroomberg, H V, Larsen, S B, Kjær Nielsen, T, Helgstrand, J T, Brasso, K & Røder, A 2024, ' Outcomes of Biopsy Grade Group 1 Prostate Cancer Diagnosis in the Danish Population ', European urology oncology, vol. 7, no. 4, pp. 770-777 . https://doi.org/10.1016/j.euo.2023.10.005

Schlagwörter: Male, Denmark, Biopsy, Prostate-Specific Antigen/blood, Prostatic Neoplasms, Prostatic Neoplasms/pathology, Middle Aged, Prostate-Specific Antigen, Denmark/epidemiology, 3. Good health, Humans, Registries, Neoplasm Grading, Watchful Waiting, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37884421
https://curis.ku.dk/ws/files/399649053/1_s2.0_S2588931123002201_main.pdf

The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis: an international multicenter analysis

Autoren: Soeterik, Timo F.W. Heetman, Joris G. Hermsen, Rick et al.

Weitere Verfasser: Soeterik, Timo F.W. Heetman, Joris G. Hermsen, Rick et al.

Quelle: Eur J Nucl Med Mol Imaging
Soeterik, Timo F W; Heetman, Joris G; Hermsen, Rick; Wever, Lieke; Lavalaye, Jules; Vinken, Maarten; Bahler, Clinton D; Yong, Courtney; Tann, Mark; Kesch, Claudia; Seifert, Robert; Telli, Tugce; Chiu, Peter Ka-Fung; Wu, Kwan Kit; Zattoni, Fabio; Evangelista, Laura; Segalla, Emma; Barone, Antonio; Ceci, Francesco; Rajwa, Pawel; ... (2024). The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis. European journal of nuclear medicine and molecular imaging, 52(1), pp. 314-325. Springer 10.1007/s00259-024-06847-y <http://dx.doi.org/10.1007/s00259-024-06847-y>
Soeterik, Timo F W; Heetman, Joris G; Hermsen, Rick; Wever, Lieke; Lavalaye, Jules; Vinken, Maarten; Bahler, Clinton D; Yong, Courtney; Tann, Mark; Kesch, Claudia; Seifert, Robert; Telli, Tugce; Chiu, Peter Ka-Fung; Wu, Kwan Kit; Zattoni, Fabio; Evangelista, Laura; Segalla, Emma; Barone, Antonio; Ceci, Francesco; Rajwa, Pawel; ... (2024). The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis. (In Press). European journal of nuclear medicine and molecular imaging Springer 10.1007/s00259-024-06847-y <http://dx.doi.org/10.1007/s00259-024-06847-y>

Schlagwörter: Male, Glutamate Carboxypeptidase II, Prostatectomy, Histology, Prostate cancer, Medizin, Prostatic Neoplasms, 610 Medicine & health, ISUP grade group, PSMA PET/CT, Middle Aged, Glutamate Carboxypeptidase II/metabolism [MeSH], Neoplasm Grading [MeSH], Aged [MeSH], Humans [MeSH], Prostatic Neoplasms/pathology [MeSH], Middle Aged [MeSH], Antigens, Surface/metabolism [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Original Article, Positron-Emission Tomography/methods [MeSH], Male [MeSH], Prostatectomy [MeSH], Prostatic Neoplasms/surgery [MeSH], 3. Good health, Radiology Nuclear Medicine and imaging, Positron-Emission Tomography, Antigens, Surface, Humans, Neoplasm Grading, Aged

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39088067
https://pure.eur.nl/en/publications/8c07571d-c1ad-4483-bfef-3172ce138f88
https://doi.org/10.1007/s00259-024-06847-y
https://rdcu.be/dPKpP
https://doi.org/10.1007/s00259-024-06847-y
https://dspace.library.uu.nl/handle/1874/458115
https://boris.unibe.ch/199436/
https://hdl.handle.net/11577/3547791
https://doi.org/10.1007/s00259-024-06847-y
https://repository.publisso.de/resource/frl:6507592
https://hdl.handle.net/2318/2080435
https://doi.org/10.1007/s00259-024-06847-y
https://www.ncbi.nlm.nih.gov/pubmed/39088067
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85200348310
https://doi.org/10.1007/s00259-024-06847-y

Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms

Autoren: Adrian Schrader Nils Netzer Thomas Hielscher et al.

Quelle: Eur Radiol

Schlagwörter: Male, Image-Guided Biopsy, Biopsy, Prostate, Prostatic Neoplasms, Middle Aged, Magnetic Resonance Imaging, Risk Assessment, 3. Good health, Prostatic neoplasms, Multiparametric magnetic resonance imaging, Nomograms, Image-Guided Biopsy/methods [MeSH], Aged [MeSH], Deep Learning [MeSH], Imaging Informatics and Artificial Intelligence, Humans [MeSH], Risk assessment, Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Prostate/diagnostic imaging [MeSH], Biopsy/methods [MeSH], Nomograms [MeSH], Male [MeSH], Prostate/pathology [MeSH], Magnetic Resonance Imaging/methods [MeSH], Deep learning, Risk Assessment/methods [MeSH], 03 medical and health sciences, Deep Learning, 0302 clinical medicine, Humans, Retrospective Studies, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38955845
https://repository.publisso.de/resource/frl:6499175

The Conundrum of Treating de novo metastatic Hormone-Sensitive Prostate Cancer

Autoren: Elst, T. van Mehra, N. Bloem, S. et al.

Quelle: Sci Rep
Scientific Reports, Vol 15, Iss 1, Pp 1-12 (2025)
Scientific Reports, 15, 1

Schlagwörter: Male, Physicians', Science, Treatments, Prostatic Neoplasms, Prostatic Neoplasms/pathology, Practice Patterns, Guidelines, Middle Aged, Article, Imaging, Surveys and Questionnaires, Medical Imaging - Radboud University Medical Center, Metastatic hormone-sensitive prostate cancer, Urology - Radboud University Medical Center, Medicine, Humans, Neoplasm Metastasis, Practice Patterns, Physicians', Medical Oncology - Radboud University Medical Center, Practice variation, Netherlands, Aged

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40216859
https://doaj.org/article/d8b2a9bab2824aeb89b45d16a004e426
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/319055
https://research.rug.nl/en/publications/201218c6-a518-4ce9-a9d5-066fdd0b1f0a
https://hdl.handle.net/11370/201218c6-a518-4ce9-a9d5-066fdd0b1f0a
https://doi.org/10.1038/s41598-025-96065-9
https://pure.amsterdamumc.nl/en/publications/6dc69cb2-4a8c-470a-83bf-3d00438172bf
https://doi.org/10.1038/s41598-025-96065-9
https://repository.ubn.ru.nl//bitstream/handle/2066/319055/319055.pdf
https://hdl.handle.net/2066/319055

Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis

Autoren: Trapp, Christian Aebersold, Daniel M Belka, Claus et al.

Weitere Verfasser: Trapp, Christian Aebersold, Daniel M Belka, Claus et al.

Quelle: Eur J Nucl Med Mol Imaging
Trapp, Christian; Aebersold, Daniel M; Belka, Claus; Casuscelli, Jozefina; Emmett, Louise; Eze, Chukwuka; Fanti, Stefano; Farolfi, Andrea; Fendler, Wolfgang; Grosu, Anca-Ligia; Guckenberger, Matthias; Hruby, George; Kirste, Simon; Koerber, Stefan A; Kroeze, Stephanie; Peeken, Jan C; Rogowski, Paul; Scharl, Sophia; Shelan, Mohamed; Spohn, Simon K B; ... (2024). Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy-a retrospective multi-institutional propensity score analysis. European journal of nuclear medicine and molecular imaging, 51(12), pp. 3770-3781. Springer 10.1007/s00259-024-06802-x <http://dx.doi.org/10.1007/s00259-024-06802-x>

Schlagwörter: Male, Glutamate Carboxypeptidase II, Medizin, 610 Medicine & health, Whole pelvis, Pelvis, Original Article, Prostate cancer, Nodal recurrence, PSMA PET/CT, Radiotherapy, Hemi pelvis, Recurrence, Positron Emission Tomography Computed Tomography, 2741 Radiology, Nuclear Medicine and Imaging, Humans, Propensity Score, Retrospective Studies, Aged, Prostatectomy, Prostatic Neoplasms, Middle Aged, 10044 Clinic for Radiation Oncology, Glutamate Carboxypeptidase II/metabolism [MeSH], Aged [MeSH], Prostatic Neoplasms/pathology [MeSH], Prostatic Neoplasms/radiotherapy [MeSH], Lymphatic Metastasis [MeSH], Male [MeSH], Neoplasm Recurrence, Local [MeSH], Propensity Score [MeSH], Prostatic Neoplasms/surgery [MeSH], Humans [MeSH], Positron Emission Tomography Computed Tomography [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antigens, Surface/metabolism [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Recurrence [MeSH], Pelvis [MeSH], Prostatectomy [MeSH], ddc, 3. Good health, Lymphatic Metastasis, Antigens, Surface, Neoplasm Recurrence, Local

Dateibeschreibung: application/pdf; 2024_Trapp_38940843.pdf - application/pdf; pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38940843
https://boris.unibe.ch/198306/
https://repository.publisso.de/resource/frl:6495659
https://epub.ub.uni-muenchen.de/126146/
https://mediatum.ub.tum.de/1770911
https://www.zora.uzh.ch/id/eprint/261653/
https://doi.org/10.5167/uzh-261653

Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate Cancer

Autoren: Andreas Michael Bucher Jan Egger Julia Dietz et al.

Quelle: J Imaging Inform Med
Journal of imaging informatics in medicine, vol. 37, no. 6, pp. 3304-3315

Schlagwörter: Male, Original Paper, Medizin, Prostate, Prostatic Neoplasms, Middle Aged, Magnetic Resonance Imaging, Diagnosis, Differential, 03 medical and health sciences, 0302 clinical medicine, Image Interpretation, Computer-Assisted, Humans, Prostatic Neoplasms/diagnostic imaging, Prostatic Neoplasms/pathology, Retrospective Studies, Aged, Magnetic Resonance Imaging/methods, Magnetic Resonance Imaging/standards, Prostate/diagnostic imaging, Prostate/pathology, Image Interpretation, Computer-Assisted/methods, Multiparametric Magnetic Resonance Imaging/methods, Multiparametric prostate MRI, Prostate cancer, Quantitative imaging, T2 mapping, Multiparametric Magnetic Resonance Imaging

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38926263
https://serval.unil.ch/resource/serval:BIB_59A51072F184.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_59A51072F1844
https://serval.unil.ch/notice/serval:BIB_59A51072F184
https://www.ncbi.nlm.nih.gov/pubmed/38926263
https://doi.org/10.1007/s10278-024-01150-6

Nutritional Supplement With Fermented Soy in Men With an Elevated Risk of Prostate Cancer and Negative Prostate Biopsies: General and Oncological Results From the Prospective PRAECAP Trial: General and Oncological Results From the Prospective PRAECAP Trial

Autoren: Van Der Eecken, Hans Vansevenant, Bram Devos, Gaetan et al.

Weitere Verfasser: Van Der Eecken, Hans Vansevenant, Bram Devos, Gaetan et al.

Quelle: Urology. 188:131-137

Schlagwörter: Male, Prostate/pathology, Glycine max, Biopsy, Prostate-Specific Antigen/blood, Prostatic Neoplasms/pathology, dietary supplements, ISOFLAVONES, Humans, Prospective Studies, Aged, 2. Zero hunger, Science & Technology, RECEPTOR, 3202 Clinical sciences, Prostate, Prostatic Neoplasms, 1103 Clinical Sciences, Urology & Nephrology, Middle Aged, Prostate-Specific Antigen, 3. Good health, Dietary Supplements, Fermentation, GROWTH, EQUOL, Life Sciences & Biomedicine

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38670272
https://biblio.vub.ac.be/vubir/(a2ba7ff8-778b-488d-a17e-5ad067b4e80a).html

Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer

Autoren: Alicia-Marie K. Beier Celina Ebersbach Tiziana Siciliano et al.

Quelle: Oncogene

Schlagwörter: Male, 0301 basic medicine, 0303 health sciences, Glutamine, Prostatic Neoplasms, Antineoplastic Agents, Docetaxel, Article, Oxidative Phosphorylation, 03 medical and health sciences, Glutaminase, Drug Resistance, Neoplasm, Cell Line, Tumor, 96/34, Cell Line, Tumor [MeSH], Prostatic Neoplasms/metabolism [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Antineoplastic Agents/pharmacology [MeSH], 96/109, 96/31, 13/51, Glutaminase/antagonists, Male [MeSH], 631/67/2327, Glutaminase/genetics [MeSH], 96/63, Drug Resistance, Neoplasm [MeSH], Docetaxel/pharmacology [MeSH], Humans [MeSH], Glutamine/metabolism [MeSH], 631/67/589/466, Oxidative Phosphorylation/drug effects [MeSH], Prostatic Neoplasms/genetics [MeSH], Glutaminase/metabolism [MeSH], Antineoplastic Agents/therapeutic use [MeSH], 38/89, 13/105, Cell Proliferation/drug effects [MeSH], article, Humans, Cell Proliferation

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38750263
https://repository.publisso.de/resource/frl:6504923

Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials

Autoren: Mohamed Shelan Vérane Achard Felix Appiagyei et al.

Quelle: Prostate Cancer Prostatic Dis
Shelan, Mohamed; Achard, Vérane; Appiagyei, Felix; Mose, Lucas; Zilli, Thomas; Fankhauser, Christian D; Zamboglou, Constantinos; Mohamad, Osama; Aebersold, Daniel M; Cathomas, Richard (2024). Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials. Prostate cancer and prostatic diseases, 27(3), pp. 422-431. Nature 10.1038/s41391-024-00829-9 <http://dx.doi.org/10.1038/s41391-024-00829-9>

Schlagwörter: Male, Salvage Therapy, Clinical Trials as Topic, Prostatic Neoplasms, 610 Medicine & health, Review Article, 3. Good health, Prostatic Neoplasms, Castration-Resistant, Phenylthiohydantoin, Nitriles, Benzamides, Androgen Receptor Antagonists, Androgen Receptor Antagonists/therapeutic use [MeSH], Prostatic Neoplasms, Castration-Resistant/pathology [MeSH], Humans [MeSH], Prospective Studies [MeSH], Salvage Therapy [MeSH], Prostatic Neoplasms, Castration-Resistant/drug therapy [MeSH], Prostatic Neoplasms/drug therapy [MeSH], Prostatic Neoplasms/pathology [MeSH], Neoplasm Recurrence, Local/pathology [MeSH], 692/699/2768/589/466, Nitriles [MeSH], Male [MeSH], Phenylthiohydantoin/therapeutic use [MeSH], Phenylthiohydantoin/analogs, Clinical Trials as Topic [MeSH], Benzamides [MeSH], review-article, 692/699/2768, Neoplasm Recurrence, Local/drug therapy [MeSH], Humans, Prospective Studies, Neoplasm Recurrence, Local

Dateibeschreibung: application/pdf; pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38589645
https://boris.unibe.ch/195803/
https://repository.publisso.de/resource/frl:6490514

Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies

Autoren: Charlie A. Hamm Georg L. Baumgärtner Anwar R. Padhani et al.

Quelle: Eur Radiol

Schlagwörter: Male, Image-Guided Biopsy, prostate-specific antigen density, Image-Guided Biopsy/methods [MeSH], Aged [MeSH], Prostate-Specific Antigen/blood [MeSH], Humans [MeSH], False Positive Reactions [MeSH], Prostatic Neoplasms/pathology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Prostatic Neoplasms/diagnostic imaging [MeSH], Prostate/diagnostic imaging [MeSH], Urogenital, Male [MeSH], Image-guided biopsy, Prostate/pathology [MeSH], Prostate-specific antigen density, Magnetic resonance imaging, Magnetic Resonance Imaging/methods [MeSH], Clinical decision-making, Prostatic neoplasms, 03 medical and health sciences, 0302 clinical medicine, interventional radiology, magnetic resonance imaging, diagnostic radiology, neuroradiology, Humans, False Positive Reactions, Retrospective Studies, Aged, clinical decision-making, ultrasound, Imaging / Radiology, Prostate, Prostatic Neoplasms, Prostate-Specific Antigen, Middle Aged, Magnetic Resonance Imaging, internal medicine

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38538841
https://repository.publisso.de/resource/frl:6490550